Clinical trials

Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients with a History of Cancer

To assess the safety of immunosupression in patients with IBD who have a history of cancer.

Multiple locations

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

This is a phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

Northwell Health Division of Gastroentereology at Great Neck | 600 Northern Boulevard | Great Neck | NY 11021

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease

Northwell Health Division of Gastroentereology at Great Neck | 600 Northern Boulevard | Great Neck | NY 11021

A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

Northwell Health Division of Gastroentereology at Great Neck | 600 Northern Boulevard | Great Neck | NY 11021

"A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection"

This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic response (SVR) after receiving a sofosbuvir (SOF)-based regimen without interferon (IFN) while participating in a Gilead-sponsored hepatitis C virus (HCV) study or commercially at selected sites...

Multiple locations

A3921210 - Open-Label Induction and Maintenance Study of Oral Cp-690,550 (Tofacitinib) In Children with Moderately to Severely Active Ulcerative Colitis

The primary objective of this study is to evaluate the efficacy of tofacitinib based on remission in pediatric participants with moderately to severely active Ulcerative Colitis (UC)...

Cohen Children's Northwell Health Physician Partners | 1991 Marcus Avenue | Lake Success | NY 11042

Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients with a History of Cancer

To assess the safety of immunosupression in patients with IBD who have a history of cancer.

Northwell Health Division of Gastroentereology at Great Neck | 600 Northern Boulevard | Great Neck | NY 11021

Predicting Crohn's & ColitIs Outcomes In the United States

PredictSURE IBD™ is an independently validated whole blood qPCR-based classifier that can reliably predict prognosis in patients with CD or UC from diagnosis; stratifying patients into high or low risk of following an aggressive disease course requiring frequent treatment escalations...

Northwell Health Division of Gastroentereology at Great Neck | 600 Northern Boulevard | Great Neck | NY 11021

A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Gastritis with or without Eosinophilic Duodenitis

This study is researching a drug called dupilumab or dupixent for patients diagnosed with eosinophilic gastroenteritis. The study aims to evaluate the effect of dupilumab or dupixent in reducing inflammation in the stomach and/or small intestine in adults and adolescents 12 years and older...

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel (PATENT-B)

To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures.

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075

Clinical trials : gastrointestinal

Employees